Plus   Neg

Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates

Vertex Pharmaceuticals Inc. (VRTX) announced a profit for its fourth quarter that climbed from the same period last year.

The company's earnings came in at $1.55 billion, or $5.97 per share. This compares with $0.10 billion, or $0.39 per share, in last year's fourth quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $337 million or $1.30 per share for the period.

Analysts had expected the company to earn $1.06 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 33.5% to $870.11 million from $651.63 million last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q4): $337 Mln. vs. $158 Mln. last year.
-EPS (Q4): $1.30 vs. $0.61 last year.
-Analysts Estimate: $1.06
-Revenue (Q4): $870.11 Mln vs. $651.63 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT